30 filings
8-K
APGN
Apexigen Inc
23 Aug 23
Completion of Acquisition or Disposition of Assets
9:01am
8-K
APGN
Apexigen Inc
22 Aug 23
Submission of Matters to a Vote of Security Holders
4:31pm
8-K
APGN
Apexigen Inc
18 Aug 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:30pm
8-K
APGN
Apexigen Inc
15 Aug 23
Other Events
4:31pm
8-K
APGN
Apexigen Inc
24 May 23
Pyxis Oncology to Acquire Apexigen
7:02am
8-K
c25hiimli2i
12 Apr 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:25pm
8-K
95rvr4dmgo7wmdgrmi
27 Feb 23
Apexigen Announces Review of Strategic Alternatives and Restructuring
4:31pm
8-K
svb96sfu 2vlx3vr0
14 Feb 23
Departure of Directors or Certain Officers
6:25am
8-K
9d95whc0qsjt8if3jar
1 Feb 23
Unregistered Sales of Equity Securities
4:06pm
8-K
0zdllk 06
25 Jan 23
Apexigen Announces Approximately $2.8 Million
4:02pm
8-K
x5zz x5tt
14 Nov 22
Changes in Registrant's Certifying Accountant
4:07pm
8-K/A
d7lg0 sjpmf
18 Aug 22
Index to Unaudited Condensed Financial Statements
4:48pm
8-K
7h798292hj 6n
4 Aug 22
Entry into a Material Definitive Agreement
4:32pm
8-K
fm6zr57a792bd
1 Aug 22
Apexigen Completes Business Combination to Become a Publicly Listed Immuno-oncology Company
9:15am
8-K
2pnb3zug4 9lwb4ws
27 Jul 22
Brookline Capital Acquisition Corp. and Apexigen, Inc. Announce Stockholder Approval of
5:41pm
8-K
pu1y lh3sdnp
18 Jul 22
Apexigen and Brookline Capital Acquisition Corp. Announce Effectiveness of Registration Statement
5:11pm
8-K
6n7 uj9l3tz
30 Jun 22
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
7:16am
8-K
rf82i
27 Jun 22
Other Events
8:00am
8-K
gvan7v7w ss85
2 Jun 22
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
5:01pm
8-K
m4xqofbn
2 May 22
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
5:36pm